ATG5 and neoplasm: The potential tumor suppressive role of ATG5 was further empathized in a study by García-Fernández et al. which showed that heterozygous loss of ATG5 in melanocyte-specific mouse models enhanced CM metastasis and compromised the response to the BRAFi dabrafenib [71].